Statistics for SCI: A Bayesian adaptive phase I/II dose-finding design accounting for semi-competing risks outcomes for immunotherapy trials
Total visits
| views | |
|---|---|
| SCI: A Bayesian adaptive phase I/II dose-finding design accounting for semi-competing risks outcomes for immunotherapy trials | 5 |
Total visits per month
| views | |
|---|---|
| October 2024 | 0 |
| November 2024 | 0 |
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 1 |
| April 2025 | 0 |
File Visits
| views | |
|---|---|
| java.util.UUID:8132a647-9c36-47ce-85b1-2caf904173a9 | 32 |
| Zhang2022SCI-CCBYNCND.pdf | 23 |
| java.util.UUID:4e7cf070-40fb-40b2-b250-e1a5cb5a2be7 | 5 |
| java.util.UUID:0978d7d0-9fdd-4a6d-aa37-52a6f1a6a21f | 4 |
Top country views
| views | |
|---|---|
| United States | 5 |
Top city views
| views | |
|---|---|
| Columbus | 2 |
| Indianapolis | 2 |
| Franklin | 1 |